CRCC
MCID: CHR177
MIFTS: 56

Chromophobe Renal Cell Carcinoma (CRCC) malady

Categories: Rare diseases, Nephrological diseases, Cancer diseases

Aliases & Classifications for Chromophobe Renal Cell Carcinoma

About this section
Sources:
11Disease Ontology, 13DISEASES, 31ICD10 via Orphanet, 35LifeMap Discovery®, 39MeSH, 45NCIt, 48NIH Rare Diseases, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Chromophobe Renal Cell Carcinoma:

Name: Chromophobe Renal Cell Carcinoma 35 11 48 54 13 68
Renal Cell Carcinoma, Chromophobe Cell 11
Chromophobe Renal Cell Adenocarcinoma 54
Chromophobe Carcinoma of Kidney 11
Chromophobe Adenocarcinoma 11
 
Chromophobe Carcinoma 68
Kidney Chromophobe 11
Chrcc 48
Crcc 48

Classifications:

Orphanet: 54 
Rare renal diseases


External Ids:

Disease Ontology11 DOID:4471
MeSH39 D002292
NCIt45 C4146
SNOMED-CT62 128667008
Orphanet54 ORPHA319303
UMLS via Orphanet69 C1266042
ICD10 via Orphanet31 C64

Summaries for Chromophobe Renal Cell Carcinoma

About this section
NIH Rare Diseases:48 Chromophobe renal cell carcinoma is a rare subtype of the most common form of kidney cancer called renal cell carcinoma (rcc). this type of cancer forms in the cells lining the small tubules in the kidney. these tubules help filter waste from the blood, making urine. chromophobe rcc accounts for about 5% of all rcc cases, and it is frequently diagnosed between ages 40 and 50. it is typically diagnosed in stage i or stage ii, and has an overall better prognosis than other types of rcc. treatment generally involves surgery. last updated: 7/1/2015

MalaCards based summary: Chromophobe Renal Cell Carcinoma, also known as renal cell carcinoma, chromophobe cell, is related to eosinophilic variant of chromophobe renal cell carcinoma and classic variant of chromophobe renal cell carcinoma, and has symptoms including flank pain An important gene associated with Chromophobe Renal Cell Carcinoma is FLCN (Folliculin), and among its related pathways are Primary Focal Segmental Glomerulosclerosis FSGS and Hepatitis C and Hepatocellular Carcinoma. Affiliated tissues include kidney, brain and liver, and related mouse phenotypes are Decreased shRNA abundance (Z-score < -2) and embryo.

Disease Ontology:11 A renal cell carcinoma that has material basis in chromophobe cell that appear pale when viewed under microscope, but that are larger and display different features than clear cells.

Related Diseases for Chromophobe Renal Cell Carcinoma

About this section

Diseases related to Chromophobe Renal Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 60)
idRelated DiseaseScoreTop Affiliating Genes
1eosinophilic variant of chromophobe renal cell carcinoma12.3
2classic variant of chromophobe renal cell carcinoma12.1
3renal cell carcinoma11.8
4birt-hogg-dube syndrome11.4
5renal cell carcinoma, papillary11.1
6renal oncocytoma10.6
7infiltrating lipoma10.3CCND1, S100A1
8skin amelanotic melanoma10.2KRT7, MME
9paranasal sinus cancer10.2KIT, KRT7, MME
10occipital encephalocele10.2KRT18, KRT8
11envenomization by bothrops lanceolatus10.2KRT7, KRT8
12wells syndrome10.2KIT, KRT18, KRT7
13woolly hair, autosomal dominant10.2KRT18, KRT8
14middle ear adenocarcinoma10.2KIT, KRT7, KRT8
15basophilic carcinoma10.2EPCAM, KRT7, S100A1
16popliteal pterygium syndrome, bartsocas-papas type10.2CCND1, KIT, S100A1
17endocrine organ benign neoplasm10.2KIT, KRT7, MME
18proteus-like syndrome10.2KRT18, KRT7, KRT8
19fallopian tube mucinous tumor10.2KRT7, MME
20advanced sleep phase syndrome10.2CCND1, KIT, KRT7
21bartholin's gland adenoid cystic carcinoma10.2KRT18, KRT7, KRT8
22ovarian embryonal carcinoma10.2KIT, KRT18, KRT8
23distal arthrogryposis10.2KRT18, KRT7, KRT8
24gallbladder cancer10.2CDH16, FLCN, KIT, MME
25malignant adult ependymoma10.2KRT18, KRT7, KRT8
26clear cell renal cell carcinoma10.1
27diffuse idiopathic skeletal hyperostosis10.1KRT7, MME
28psoriasis susceptibility 1310.1FLCN, HNF1B, KRT7
2913q12.3 microdeletion syndrome10.1CCND1, S100A1, TGFB1
30amyloidosis, hereditary, transthyretin-related10.1KIT, KRT7, KRT8
31mongolian spot10.1KRT18, KRT7, KRT8, S100A1
32malignant pleural solitary fibrous tumor10.1CCND1, KIT, KRT7, MME
33sarcomatoid mesothelioma10.1KRT18, KRT7, KRT8, MME
34nodular tenosynovitis10.1KRT18, KRT7, KRT8, MME
35thyroid carcinoma, papillary, with papillary renal neoplasia10.1CDH16, FLCN, KIT, KRT7, MME
36progesterone-receptor positive breast cancer10.1CCND1, CLDN7, KRT8
37dysembryoplastic neuroepithelial tumor10.0KRT18, KRT7, KRT8
38lipoadenoma10.0CDH16, FLCN, KIT, KRT8, MME
39testicular cancer10.0CCND1, EPCAM, KIT, KRT7
40neuroendocrine tumor10.0
41purpura10.0
42gastroesophageal junction adenocarcinoma9.9CCND1, EPCAM, KRT7
43proctitis9.9CCND1, EPCAM, KIT, KRT7, TGFB1
44adenocarcinoma9.9
45chondrosarcoma9.8
46hepatitis9.8
47paraganglioma9.8
48lymphoma9.8
49dermatomyositis9.8
50hypospadias9.8

Graphical network of the top 20 diseases related to Chromophobe Renal Cell Carcinoma:



Diseases related to chromophobe renal cell carcinoma

Symptoms & Phenotypes for Chromophobe Renal Cell Carcinoma

About this section

UMLS symptoms related to Chromophobe Renal Cell Carcinoma:


flank pain

GenomeRNAi Phenotypes related to Chromophobe Renal Cell Carcinoma according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-849.1KRT18, KRT7, KRT8, TGFB1

MGI Mouse Phenotypes related to Chromophobe Renal Cell Carcinoma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053808.7EPCAM, FLCN, HNF1B, KIT, KRT18, KRT8
2MP:00053818.1CAV1, CCND1, EPCAM, HNF1A, KIT, KRT8
3MP:00053708.0CAV1, HNF1A, HNF1B, KIT, KRT18, KRT8
4MP:00053677.5CAV1, CLDN7, CLDN8, FLCN, HNF1A, HNF1B
5MP:00107717.5CAV1, CCND1, CLDN7, HNF1A, KIT, MME
6MP:00053877.0CAV1, CCND1, EPCAM, FLCN, HNF1B, KIT
7MP:00053976.8CAV1, CCND1, CLDN7, EPCAM, FLCN, KIT
8MP:00053786.4CAV1, CCND1, CLDN7, CLDN8, EPCAM, FLCN
9MP:00107686.1CAV1, CCND1, CLDN7, EPCAM, FLCN, HNF1A
10MP:00053765.5CAV1, CCND1, CLDN7, CLDN8, EPCAM, FLCN

Drugs & Therapeutics for Chromophobe Renal Cell Carcinoma

About this section

Drugs for Chromophobe Renal Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Sorafenibapproved, investigationalPhase 1, Phase 2700284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
2
Sirolimusapproved, investigationalPhase 2194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
3
Sunitinibapproved, investigationalPhase 2510341031-54-7, 557795-19-45329102
Synonyms:
(2S)-2-hydroxybutanedioic acid
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
326914-13-0
341031-54-7
5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE
557795-19-4
AC1NS62J
AC1O5CMQ
AKOS005145765
Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
CHEBI:38940
CHEBI:550864
CHEMBL1567
CHEMBL535
CID5329102
CID6456015
D06402
D08552
DB01268
DB07417
EN002687
FT-0083555
FT-0083556
I01-1229
K00588a
KS-5022
LS-186078
LS-187023
LS-187648
MolPort-003-986-763
N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
NCGC00164631-01
 
NSC736511
NSC750690
PDGF TK antagonist
PHA-290940AD
PNU-290940AD
S1042_Selleck
ST51053712
SU 011248
SU 11248
SU-010398
SU-011248 L-malate salt
SU-11248
SU-11248 L-malate salt
SU-11248J
SU-12662
SU010398
SU011248
SU011248 L-malate salt
SU11248
Su-011248
Sunitanib
Sunitinib
Sunitinib (INN)
Sunitinib (free base)
Sunitinib malate
Sunitinib malate (JAN/USAN)
Sunitinib malate [USAN]
Sunitinibum
Sutent
Sutent (TN)
Sutent, SU-11248
TL8002546
UNII-LVX8N1UT73
UNII-V99T50803M
sunitinib
sunitinibum
4
Bevacizumabapproved, investigationalPhase 1, Phase 22020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
5
EverolimusapprovedPhase 21940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
6
Miconazoleapproved, investigational, vet_approvedPhase 2370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
7
Nicotinamideapproved, NutraceuticalPhase 1, Phase 291998-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3 amide
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
8
Folic Acidapproved, nutraceutical, vet_approvedPhase 1, Phase 2439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
9
Niacinapproved, investigational, nutraceuticalPhase 1, Phase 292359-67-6938
Synonyms:
3-Carboxylpyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
3-carboxypyridine
Acide Nicotinique
Acido nicotinico
Acidum Nicotinicum
Akotin
Anti-pellagra vitamin
Apelagrin
Daskil
Efacin
Enduracin
Linic
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacine
Niacor
Nicacid
Nicamin
Nicangin
 
Nico-Span
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
Nicotinate
Nicotinic Acid
Nicotinic acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
PP Factor
Pellagra preventive factor
Pellagrin
Pelonin
Pyridine-beta-carboxylic acid
Slo-niacin
Vitamin B3
Wampocap
beta-Pyridinecarboxylic acid
pyridine-β-carboxylic acid
β-pyridinecarboxylic acid
10
Epothilone Bexperimental, investigationalPhase 267152044-54-7
Synonyms:
(−)-epothilone B
 
Epo B
Patupilone
11Antifungal AgentsPhase 23696
12Antibiotics, AntitubercularPhase 27180
13Anti-Infective AgentsPhase 222062
14Antimitotic AgentsPhase 25657
15Immunosuppressive AgentsPhase 213086
16Anti-Bacterial AgentsPhase 211226
17Vitamin B ComplexPhase 1, Phase 24337
18Nicotinic AcidsPhase 1, Phase 2923
19MicronutrientsPhase 1, Phase 26001
20Angiogenesis Modulating AgentsPhase 1, Phase 24185
21VitaminsPhase 1, Phase 25282
22Protein Kinase InhibitorsPhase 1, Phase 23689
23Angiogenesis InhibitorsPhase 1, Phase 24257
24EpothilonesPhase 2152
25Trace ElementsPhase 1, Phase 26001
26
LactitolPhase 2336585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
27Vitamin B9NutraceuticalPhase 1, Phase 24392
28FolateNutraceuticalPhase 1, Phase 24392
29Vitamin B3NutraceuticalPhase 1, Phase 2923

Interventional clinical trials:

(show all 11)
idNameStatusNCT IDPhase
1Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney CancerCompletedNCT00126503Phase 1, Phase 2
2Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaCompletedNCT01108445Phase 2
3pazopanib_NCRCC,Ph2 STUDYCompletedNCT01538238Phase 2
4Sunitinib Malate in Patients With Non-Clear Cell Renal Cell CancerCompletedNCT00465179Phase 2
5EPO906 Therapy in Patients With Advanced Kidney CancerCompletedNCT00035243Phase 2
6Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal CancerRecruitingNCT02504892Phase 2
7Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney CancerRecruitingNCT01767636Phase 2
8Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell CarcinomaActive, not recruitingNCT01185366Phase 2
9UNISoN: anzUp Nivo Then Ipi+Nivo in Sequential Non-clear Cell.Not yet recruitingNCT03177239Phase 2
10A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)Not yet recruitingNCT03145909Phase 1
11Evaluation of Diagnostic Value of Molecular Markers in Renal CancerTerminatedNCT00491621

Search NIH Clinical Center for Chromophobe Renal Cell Carcinoma

Genetic Tests for Chromophobe Renal Cell Carcinoma

About this section

Anatomical Context for Chromophobe Renal Cell Carcinoma

About this section

MalaCards organs/tissues related to Chromophobe Renal Cell Carcinoma:

36
Kidney, Brain, Liver, B cells, Myeloid, T cells, Pituitary

Publications for Chromophobe Renal Cell Carcinoma

About this section

Articles related to Chromophobe Renal Cell Carcinoma:

(show top 50)    (show all 240)
idTitleAuthorsYear
1
c-Met in chromophobe renal cell carcinoma. (28035577)
2017
2
Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma. (27258182)
2016
3
Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma. (27478468)
2016
4
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib. (27382030)
2016
5
Chromophobe renal cell carcinoma occurring in the renal allograft of a transplant recipient presenting with weight loss. (26787581)
2016
6
An atypical case of dermatomyositis associated with chromophobe renal cell carcinoma. (26786527)
2016
7
Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis. (26589610)
2016
8
Chromophobe renal cell carcinoma mimicking cortical invasion by synchronous invasive urothelial carcinoma of the intra-renal collecting system on CT urography. (27256197)
2016
9
Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates. (26684814)
2016
10
Rare Case of Hybrid Oncocytoma and Chromophobe Renal Cell Carcinoma in a Pediatric Patient. (26718018)
2016
11
A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. (26951082)
2016
12
Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. (27631338)
2016
13
Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-DubAc syndrome-associated chromophobe renal cell carcinomas. (26980015)
2016
14
Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma. (26870150)
2016
15
Metastatic chromophobe renal cell carcinoma to the brain. (26589090)
2016
16
Genetic alterations of HER genes in chromophobe renal cell carcinoma. (26998131)
2016
17
Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma. (27799788)
2016
18
PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception? (27696122)
2016
19
Robot-assisted heminephrectomy for chromophobe renal cell carcinoma in L-shaped fused crossed ectopia: Surgical challenge. (26495075)
2015
20
Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma. (25972369)
2015
21
BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma. (26091477)
2015
22
DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma. (25596994)
2015
23
Chromophobe renal cell carcinoma, eosinophilic variant with papillary growth: a case report. (26722580)
2015
24
Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature. (26031603)
2015
25
Resection of bulky chromophobe renal cell carcinoma resolved severe idiopathic thrombocytopenic purpura: A case report. (26354444)
2015
26
Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies. (25859550)
2015
27
Editorial Comment to Resection of bulky chromophobe renal cell carcinoma resolved severe idiopathic thrombocytopenic purpura: A case report. (26394806)
2015
28
Eosinophilic variant of chromophobe renal cell carcinoma. (25552800)
2015
29
Sarcomatoid chromophobe renal cell carcinoma: A rare entity with prognostic significance. (26881614)
2015
30
Chromophobe renal cell carcinoma of the kidney with neuroendocrine differentiation: A case report with review of literature. (26229333)
2015
31
Chromophobe Renal Cell Carcinoma is the Most Common Nonclear Renal Cell Carcinoma in Young Women: Results from the SEER Database. (26555952)
2015
32
Chromophobe renal cell carcinoma, oncocytic variant: Cytological and ultrastructural observations. (26729980)
2015
33
Chromophobe renal cell carcinoma with and without sarcomatoid change: a clinicopathological, comparative genomic hybridization, and whole-exome sequencing study. (26807193)
2015
34
Chromophobe renal cell carcinoma recurrence in the ureter: A late presentation of a rare metastasis. (26425244)
2015
35
HNF1I^ and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies. (25739652)
2015
36
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma. (25981392)
2015
37
TGF-I^1 expression in chromophobe renal cell carcinoma and renal oncocytoma. (24704995)
2014
38
Relating prognosis in chromophobe renal cell carcinoma to the chromophobe tumor grading system. (24741411)
2014
39
Immunohistochemical Analysis of Cytochrome c Oxidase Facilitates Differentiation Between Oncocytoma and Chromophobe Renal Cell Carcinoma. (25265428)
2014
40
C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma. (24875296)
2014
41
Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: a case report. (25291862)
2014
42
Omental Nodular Deposits of Recurrent Chromophobe Renal Cell Carcinoma Seen on FDG-PET/CT. (25337437)
2014
43
Chromophobe renal cell carcinoma with sarcomatoid changes: case report and review of literature. (24982777)
2014
44
The somatic genomic landscape of chromophobe renal cell carcinoma. (25155756)
2014
45
Chromophobe renal cell carcinoma associated with eosinophilia: A report of three cases. (24944603)
2014
46
Genomic profiling provides insight into chromophobe renal cell carcinoma. (25367957)
2014
47
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size. (25178561)
2014
48
Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: Could it be a general phenomenon? (25314913)
2014
49
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma. (25305793)
2014
50
Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma. (24696789)
2014

Variations for Chromophobe Renal Cell Carcinoma

About this section

Clinvar genetic disease variations for Chromophobe Renal Cell Carcinoma:

5
id Gene Variation Type Significance SNP ID Assembly Location
1HNF1BNM_ 000458.3(HNF1B): c.46delC (p.Leu16Cysfs)deletionPathogenicrs587776771GRCh37Chr 17, 36104830: 36104830
2HNF1ANM_ 000545.6(HNF1A): c.92G> A (p.Gly31Asp)SNVPathogenicrs137853247GRCh37Chr 12, 121416663: 121416663
3FLCNFLCN, 2-BP DEL, 1284TC AND 2-BP INS, 1284ACindelPathogenic

Cosmic variations for Chromophobe Renal Cell Carcinoma:

8 (show all 47)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM26614RABGAP1kidney,NS,carcinoma,renal cellc.1533T>Ap.H511Q22
2COSM30531COPS4kidney,NS,carcinoma,renal cellc.385G>Cp.G129R22
3COSM30471ARHGAP20kidney,NS,carcinoma,renal cellc.1355A>Gp.D452G22
4COSM30474TRIOkidney,NS,carcinoma,renal cellc.9008A>Gp.N3003S22
5COSM25654CDC5Lkidney,NS,carcinoma,renal cellc.1196G>Ap.R399Q22
6COSM25676VHLkidney,NS,carcinoma,renal cellc.485G>Tp.C162F22
7COSM28415DOCK1kidney,NS,carcinoma,renal cellc.1306G>Tp.D436Y22
8COSM30502ITPR3kidney,NS,carcinoma,renal cellc.4574G>Tp.C1525F22
9COSM27618KMT2Akidney,NS,carcinoma,renal cellc.5711C>Tp.A1904V22
10COSM30530PTPN22kidney,NS,carcinoma,renal cellc.209G>Cp.R70P22
11COSM26594RNF144Akidney,NS,carcinoma,renal cellc.410C>Tp.A137V22
12COSM27269UMPSkidney,NS,carcinoma,renal cellc.528G>Ap.L176L22
13COSM26987RGS7kidney,NS,carcinoma,renal cellc.169T>Cp.F57L22
14COSM30472ARHGEF11kidney,NS,renal cell carcinoma,chromophobec.583-1G>Ap.?21
15COSM26590KALRNkidney,NS,renal cell carcinoma,chromophobec.236G>Ap.R79H21
16COSM26986NCAPD2kidney,NS,renal cell carcinoma,chromophobec.2092C>Tp.R698C21
17COSM26613BRINP3kidney,NS,renal cell carcinoma,chromophobec.346C>Tp.R116C21
18COSM25667MMP3kidney,NS,renal cell carcinoma,chromophobec.946C>Tp.R316C21
19COSM28464GDF11kidney,NS,renal cell carcinoma,chromophobec.935G>Ap.R312H21
20COSM25714PGM1kidney,NS,renal cell carcinoma,chromophobec.962C>Tp.P321L21
21COSM26995ESRRGkidney,NS,renal cell carcinoma,chromophobec.122C>Tp.T41M21
22COSM28440MYBL2kidney,NS,renal cell carcinoma,chromophobec.1249C>Tp.R417C21
23COSM26593PCkidney,NS,renal cell carcinoma,chromophobec.2525G>Ap.R842Q21
24COSM26615TMEM74kidney,NS,renal cell carcinoma,chromophobec.289C>Tp.R97W21
25COSM18028VHLkidney,NS,carcinoma,chromophobe renal cell carcinomac.257C>Tp.P86L16
26COSM20745IGF1Rkidney,NS,carcinoma,chromophobe renal cell carcinomac.313G>Cp.V105L16
27COSM30368KMT2Dkidney,NS,carcinoma,chromophobe renal cell carcinomac.960C>Tp.C320C16
28COSM45322TP53kidney,NS,carcinoma,chromophobe renal cell carcinomac.757A>Gp.T253A16
29COSM11450TP53kidney,NS,carcinoma,chromophobe renal cell carcinomac.644G>Tp.S215I16
30COSM43697TP53kidney,NS,carcinoma,chromophobe renal cell carcinomac.832C>Ap.P278T16
31COSM11071TP53kidney,NS,carcinoma,chromophobe renal cell carcinomac.1009C>Tp.R337C16
32COSM10659TP53kidney,NS,carcinoma,chromophobe renal cell carcinomac.817C>Tp.R273C16
33COSM30365KMT2Dkidney,NS,carcinoma,chromophobe renal cell carcinomac.9236T>Cp.M3079T16
34COSM17806VHLkidney,NS,carcinoma,chromophobe renal cell carcinomac.333C>Tp.S111S16
35COSM17957VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.292T>Gp.Y98D13
36COSM17875VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.234T>Gp.N78K13
37COSM26002TAF2kidney,NS,renal cell carcinoma,chromophobe cellc.851T>Gp.L284R13
38COSM28454KDM5Ckidney,NS,renal cell carcinoma,chromophobe cellc.1933G>Tp.E645*13
39COSM14305VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.266T>Ap.L89H13
40COSM26014CUL3kidney,NS,renal cell carcinoma,chromophobe cellc.608A>Tp.E203V13
41COSM52899PBRM1kidney,NS,carcinoma,renal cell carcinoma unclassifiedc.3805A>Tp.K1269*13
42COSM30526NFYCkidney,NS,renal cell carcinoma,chromophobe cellc.519C>Gp.I173M13
43COSM14389VHLkidney,NS,renal cell carcinoma,chromophobe cellc.452T>Gp.I151S13
44COSM17983VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.500G>Ap.R167Q13
45COSM14312VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.353T>Cp.L118P13
46COSM14425VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.341-2A>Tp.?13
47COSM14382VHLkidney,NS,carcinoma,renal cell carcinoma unclassifiedc.245G>Cp.R82P13

Expression for genes affiliated with Chromophobe Renal Cell Carcinoma

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Chromophobe Renal Cell Carcinoma patients vs. healthy controls: 35 (show all 297)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1SLC12A1solute carrier family 12 (sodium/potassium/chloride transporter), member 1Kidney-10.960.000
2NAT8N-acetyltransferase 8 (GCN5-related, putative)Kidney-9.850.000
3CALB1calbindin 1, 28kDaKidney-9.440.000
4GLYATglycine-N-acyltransferaseKidney-9.240.000
5KCNJ16potassium channel, inwardly rectifying subfamily J, member 16Kidney-9.210.000
6FABP1fatty acid binding protein 1, liverKidney-8.950.000
7MIOXmyo-inositol oxygenaseKidney-8.890.000
8PLGplasminogenKidney-8.670.000
9NPHS2nephrosis 2, idiopathic, steroid-resistant (podocin)Kidney-8.340.000
10CFTRcystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Kidney+8.220.000
11G6PCglucose-6-phosphatase, catalytic subunitKidney-8.140.000
12SLC16A9solute carrier family 16, member 9Kidney-8.050.000
13ACMSDaminocarboxymuconate semialdehyde decarboxylaseKidney-8.040.000
14ALDOBaldolase B, fructose-bisphosphateKidney-8.030.000
15GSTA1glutathione S-transferase alpha 1Kidney-8.010.000
16SCNN1Gsodium channel, non voltage gated 1 gamma subunitKidney-7.850.000
17HS6ST2heparan sulfate 6-O-sulfotransferase 2Kidney-7.840.000
18PDZK1IP1PDZK1 interacting protein 1Kidney-7.830.000
19TSPAN8tetraspanin 8Kidney-7.820.000
20BHMTbetaine--homocysteine S-methyltransferaseKidney-7.750.000
21FMO1flavin containing monooxygenase 1Kidney-7.570.000
22BBOX1butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1Kidney-7.570.000
23DZIP1DAZ interacting zinc finger protein 1Kidney-7.560.000
24RNF128ring finger protein 128, E3 ubiquitin protein ligaseKidney-7.530.000
25ANPEPalanyl (membrane) aminopeptidaseKidney-7.510.000
26MUC15mucin 15, cell surface associatedKidney-7.450.000
27AGXT2alanine--glyoxylate aminotransferase 2Kidney-7.430.000
28ALDH8A1aldehyde dehydrogenase 8 family, member A1Kidney-7.360.000
29SOSTDC1sclerostin domain containing 1Kidney-7.310.000
30SLC7A13solute carrier family 7 (anionic amino acid transporter), member 13Kidney-7.310.000
31FAM151Afamily with sequence similarity 151, member AKidney-7.260.000
32TOXthymocyte selection-associated high mobility group boxKidney-7.230.000
33SLC22A8solute carrier family 22 (organic anion transporter), member 8Kidney-7.200.000
34DHRS2dehydrogenase/reductase (SDR family) member 2Kidney+7.180.000
35UGT2A3UDP glucuronosyltransferase 2 family, polypeptide A3Kidney-7.130.002
36TYRP1tyrosinase-related protein 1Kidney-7.110.000
37GPC5glypican 5Kidney-7.100.000
38PDZK1PDZ domain containing 1Kidney-7.090.002
39KRT19keratin 19, type IKidney-7.030.000
40FGFR3fibroblast growth factor receptor 3Kidney-7.020.000
41CLIC5chloride intracellular channel 5Kidney-7.020.001
42SLC6A13solute carrier family 6 (neurotransmitter transporter), member 13Kidney-6.970.000
43CYP4A11cytochrome P450, family 4, subfamily A, polypeptide 11Kidney-6.900.000
44CYP4A22cytochrome P450, family 4, subfamily A, polypeptide 22Kidney-6.890.000
45SLC22A2solute carrier family 22 (organic cation transporter), member 2Kidney-6.890.000
46GLYATL1glycine-N-acyltransferase-like 1Kidney-6.890.000
47GBA3glucosidase, beta, acid 3 (gene/pseudogene)Kidney-6.880.000
48UPB1ureidopropionase, betaKidney-6.880.000
49LUMlumicanKidney-6.880.000
50NTRK2neurotrophic tyrosine kinase, receptor, type 2Kidney-6.820.000
51SLC2A2solute carrier family 2 (facilitated glucose transporter), member 2Kidney-6.810.000
52MMEmembrane metallo-endopeptidaseKidney-6.760.000
53SLC13A3solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3Kidney-6.740.000
54IRX2iroquois homeobox 2Kidney-6.730.000
55TMC5transmembrane channel-like 5Kidney+6.720.001
56GCgroup-specific component (vitamin D binding protein)Kidney-6.700.000
57C2orf40chromosome 2 open reading frame 40Kidney-6.630.001
58CXCL14chemokine (C-X-C motif) ligand 14Kidney-6.620.014
59KLK15kallikrein-related peptidase 15Kidney+6.620.000
60SLC6A19solute carrier family 6 (neutral amino acid transporter), member 19Kidney-6.610.000
61HAO2hydroxyacid oxidase 2 (long chain)Kidney-6.570.000
62MFSD4major facilitator superfamily domain containing 4Kidney-6.550.001
63CACNA2D1calcium channel, voltage-dependent, alpha 2/delta subunit 1Kidney-6.540.000
64FLRT3fibronectin leucine rich transmembrane protein 3Kidney-6.530.000
65RALYLRALY RNA binding protein-likeKidney-6.510.000
66NPY1Rneuropeptide Y receptor Y1Kidney-6.510.000
67PAHphenylalanine hydroxylaseKidney-6.500.005
68CLDN10claudin 10Kidney-6.470.001
69MGST1microsomal glutathione S-transferase 1Kidney-6.460.000
70CYP4F3cytochrome P450, family 4, subfamily F, polypeptide 3Kidney-6.460.000
71C1Scomplement component 1, s subcomponentKidney-6.430.000
72KCNJ1potassium channel, inwardly rectifying subfamily J, member 1Kidney-6.410.000
73MYH11myosin, heavy chain 11, smooth muscleKidney-6.400.000
74MAOBmonoamine oxidase BKidney-6.400.001
75CYS1cystin 1Kidney-6.390.028
76CAPN3calpain 3Kidney-6.370.000
77DCNdecorinKidney-6.360.000
78GPM6Bglycoprotein M6BKidney-6.350.000
79ASS1argininosuccinate synthase 1Kidney-6.350.000
80KLklothoKidney-6.340.000
81SFRP1secreted frizzled-related protein 1Kidney-6.330.000
82SLC16A4solute carrier family 16, member 4Kidney-6.320.000
83RBP4retinol binding protein 4, plasmaKidney-6.290.000
84SLC47A1solute carrier family 47 (multidrug and toxin extrusion), member 1Kidney-6.280.000
85KNG1kininogen 1Kidney-6.270.002
86GLIS3GLIS family zinc finger 3Kidney-6.270.000
87DDCdopa decarboxylase (aromatic L-amino acid decarboxylase)Kidney-6.260.000
88ADH1Balcohol dehydrogenase 1B (class I), beta polypeptideKidney-6.260.000
89PAPPApregnancy-associated plasma protein A, pappalysin 1Kidney-6.250.000
90PLNphospholambanKidney-6.250.000
91FLJ22763uncharacterized LOC401081Kidney-6.240.000
92XPNPEP2X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-boundKidney-6.190.000
93ABCA8ATP-binding cassette, sub-family A (ABC1), member 8Kidney-6.180.001
94CLRN3clarin 3Kidney-6.170.000
95ACOX2acyl-CoA oxidase 2, branched chainKidney-6.160.002
96WNK4WNK lysine deficient protein kinase 4Kidney-6.150.000
97HPD4-hydroxyphenylpyruvate dioxygenaseKidney-6.150.006
98DPYSdihydropyrimidinaseKidney-6.150.000
99AKAP12A kinase (PRKA) anchor protein 12Kidney-6.140.000
100HNF4Ahepatocyte nuclear factor 4, alphaKidney-6.120.000
101DIO1deiodinase, iodothyronine, type IKidney-6.090.000
102C7complement component 7Kidney-6.050.001
103AQP4aquaporin 4Kidney-6.050.001
104CDHR5cadherin-related family member 5Kidney-6.040.000
105AQP2aquaporin 2 (collecting duct)Kidney-6.040.000
106UGT2B28UDP glucuronosyltransferase 2 family, polypeptide B28Kidney-6.030.000
107LRRC19leucine rich repeat containing 19Kidney-5.990.004
108SLC22A6solute carrier family 22 (organic anion transporter), member 6Kidney-5.990.000
109AK4adenylate kinase 4Kidney-5.950.000
110LGALS2lectin, galactoside-binding, soluble, 2Kidney-5.920.000
111CXCL12chemokine (C-X-C motif) ligand 12Kidney-5.910.000
112ST8SIA5ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5Kidney+5.880.000
113PCK1phosphoenolpyruvate carboxykinase 1 (soluble)Kidney-5.880.004
114PPP1R1Aprotein phosphatase 1, regulatory (inhibitor) subunit 1AKidney-5.880.005
115CRHBPcorticotropin releasing hormone binding proteinKidney-5.870.000
116PTGDSprostaglandin D2 synthase 21kDa (brain)Kidney-5.870.000
117CFIcomplement factor IKidney-5.870.003
118HRGhistidine-rich glycoproteinKidney-5.860.000
119SMTNL2smoothelin-like 2Kidney-5.850.000
120AFF3AF4/FMR2 family, member 3Kidney-5.850.000
121LSAMPlimbic system-associated membrane proteinKidney+5.850.000
122CRYAAcrystallin, alpha AKidney-5.830.000
123KCNJ10potassium channel, inwardly rectifying subfamily J, member 10Kidney-5.820.000
124SOSTsclerostinKidney-5.790.000
125FBLN5fibulin 5Kidney-5.770.000
126SLC13A1solute carrier family 13 (sodium/sulfate symporter), member 1Kidney-5.760.001
127CTGFconnective tissue growth factorKidney-5.760.000
128ENPEPglutamyl aminopeptidase (aminopeptidase A)Kidney-5.740.000
129ACSM2Aacyl-CoA synthetase medium-chain family member 2AKidney-5.730.000
130TPRG1tumor protein p63 regulated 1Kidney+5.720.030
131GLDCglycine dehydrogenase (decarboxylating)Kidney-5.710.000
132FOXC1forkhead box C1Kidney-5.700.002
133SLC5A12solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12Kidney-5.690.000
134IL17RBinterleukin 17 receptor BKidney-5.690.000
135COL4A5collagen, type IV, alpha 5Kidney-5.680.000
136GALNT14polypeptide N-acetylgalactosaminyltransferase 14Kidney-5.670.000
137SHMT1serine hydroxymethyltransferase 1 (soluble)Kidney-5.670.000
138CASRcalcium-sensing receptorKidney-5.660.001
139TMEM45Btransmembrane protein 45BKidney-5.650.040
140UPP2uridine phosphorylase 2Kidney-5.640.000
141LINC00588long intergenic non-protein coding RNA 588Kidney+5.630.002
142APOC1apolipoprotein C-IKidney+5.630.000
143FHL1four and a half LIM domains 1Kidney-5.620.000
144GDAguanine deaminaseKidney-5.620.001
145LRP2low density lipoprotein receptor-related protein 2Kidney-5.610.000
146SLC12A3solute carrier family 12 (sodium/chloride transporter), member 3Kidney-5.590.000
147UMODuromodulinKidney-5.590.000
148RBMS3RNA binding motif, single stranded interacting protein 3Kidney-5.590.001
149TRIM6tripartite motif containing 6Kidney-5.590.002
150TFPItissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)Kidney-5.580.000
151UGT3A1UDP glycosyltransferase 3 family, polypeptide A1Kidney-5.580.000
152DYNLRB2dynein, light chain, roadblock-type 2Kidney-5.580.000
153SLC22A3solute carrier family 22 (organic cation transporter), member 3Kidney-5.570.000
154ACE2angiotensin I converting enzyme 2Kidney-5.560.001
155DPEP1dipeptidase 1 (renal)Kidney-5.560.000
156MTTPmicrosomal triglyceride transfer proteinKidney-5.540.000
157CAPN6calpain 6Kidney-5.540.003
158AQP1aquaporin 1 (Colton blood group)Kidney-5.540.000
159ALBalbuminKidney-5.540.000
160ASPAaspartoacylaseKidney-5.520.001
161CYR61cysteine-rich, angiogenic inducer, 61Kidney-5.520.000
162ABCC6ATP-binding cassette, sub-family C (CFTR/MRP), member 6Kidney-5.520.001
163NR1H4nuclear receptor subfamily 1, group H, member 4Kidney-5.520.000
164FERMT1fermitin family member 1Kidney-5.510.002
165SYNPO2synaptopodin 2Kidney-5.500.000
166NRXN3neurexin 3Kidney+5.480.000
167CTXN3cortexin 3Kidney-5.480.000
168ENPP6ectonucleotide pyrophosphatase/phosphodiesterase 6Kidney-5.480.000
169FTCDformimidoyltransferase cyclodeaminaseKidney-5.450.000
170SLC5A10solute carrier family 5 (sodium/sugar cotransporter), member 10Kidney-5.450.000
171FOSBFBJ murine osteosarcoma viral oncogene homolog BKidney-5.440.000
172FBLN1fibulin 1Kidney-5.420.000
173SYNGR3synaptogyrin 3Kidney+5.340.000
174STXBP6syntaxin binding protein 6 (amisyn)Kidney+5.250.004
175CLNKcytokine-dependent hematopoietic cell linkerKidney+5.130.000
176TMPRSS11Etransmembrane protease, serine 11EKidney+5.120.002
177LRRC31leucine rich repeat containing 31Kidney+4.940.001
178AKR1C2aldo-keto reductase family 1, member C2Kidney+4.850.009
179CCL18chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)Kidney+4.710.015
180CTNNA2catenin (cadherin-associated protein), alpha 2Kidney+4.680.002
181KLK4kallikrein-related peptidase 4Kidney+4.640.004
182ADCY1adenylate cyclase 1 (brain)Kidney+4.460.006
183SPINK7serine peptidase inhibitor, Kazal type 7 (putative)Kidney+4.380.001
184CHRM1cholinergic receptor, muscarinic 1Kidney+4.370.037
185WBSCR17Williams-Beuren syndrome chromosome region 17Kidney+4.360.001
186HS6ST3heparan sulfate 6-O-sulfotransferase 3Kidney+4.360.001
187BCANbrevicanKidney+4.360.001
188SSTsomatostatinKidney+4.330.037
189ABHD11abhydrolase domain containing 11Kidney+4.300.003
190DOCK10dedicator of cytokinesis 10Kidney+4.150.000
191CNTNAP5contactin associated protein-like 5Kidney+4.150.001
192HTRA4HtrA serine peptidase 4Kidney+4.130.009
193RGS4regulator of G-protein signaling 4Kidney+4.120.009
194TSPAN5tetraspanin 5Kidney+4.120.002
195Mar-11membrane-associated ring finger (C3HC4) 11Kidney+4.080.021
196ANO4anoctamin 4Kidney+4.060.019
197SMOC1SPARC related modular calcium binding 1Kidney+3.980.019
198KCNG1potassium channel, voltage gated modifier subfamily G, member 1Kidney+3.970.002
199CCDC34coiled-coil domain containing 34Kidney+3.970.000
200NRG2neuregulin 2Kidney+3.970.024
201TMEM255Atransmembrane protein 255AKidney+3.960.048
202MFSD7major facilitator superfamily domain containing 7Kidney+3.950.006
203RHCGRh family, C glycoproteinKidney+3.940.000
204LOC100289026uncharacterized LOC100289026Kidney+3.930.036
205KLK3kallikrein-related peptidase 3Kidney+3.920.001
206ADCYAP1adenylate cyclase activating polypeptide 1 (pituitary)Kidney+3.900.009
207PSG3pregnancy specific beta-1-glycoprotein 3Kidney+3.900.003
208SDCBP2syndecan binding protein (syntenin) 2Kidney+3.890.000
209PCGF3polycomb group ring finger 3Kidney+3.890.001
210STAP1signal transducing adaptor family member 1Kidney+3.870.000
211SAMD4Asterile alpha motif domain containing 4AKidney+3.870.000
212DMRT2doublesex and mab-3 related transcription factor 2Kidney+3.860.000
213LOC157740uncharacterized protein C8orf9Kidney+3.840.009
214CR1Lcomplement component (3b/4b) receptor 1-likeKidney+3.810.000
215SFTPBsurfactant protein BKidney+3.790.027
216PVALBparvalbuminKidney+3.760.000
217PLEK2pleckstrin 2Kidney+3.740.001
218ADAM2ADAM metallopeptidase domain 2Kidney+3.730.000
219CDAcytidine deaminaseKidney+3.710.015
220TMEM38Atransmembrane protein 38AKidney+3.700.005
221FOXI1forkhead box I1Kidney+3.680.000
222GPSM2G-protein signaling modulator 2Kidney+3.680.021
223HIST1H2AGhistone cluster 1, H2agKidney+3.680.038
224HEPACAM2HEPACAM family member 2Kidney+3.670.000
225LOC441052uncharacterized LOC441052Kidney+3.660.009
226HHATLhedgehog acyltransferase-likeKidney+3.660.031
227PARVBparvin, betaKidney+3.660.001
228KITv-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologKidney+3.640.000
229BAALCbrain and acute leukemia, cytoplasmicKidney+3.630.003
230PSD3pleckstrin and Sec7 domain containing 3Kidney+3.610.002
231ATP6V0D2ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2Kidney+3.610.001
232Mar-01membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligaseKidney+3.610.023
233CREB3L1cAMP responsive element binding protein 3-like 1Kidney+3.610.001
234NINJ2ninjurin 2Kidney+3.590.033
235USP7ubiquitin specific peptidase 7 (herpes virus-associated)Kidney+3.580.034
236NTN1netrin 1Kidney+3.540.004
237BCAS4breast carcinoma amplified sequence 4Kidney+3.540.018
238MIB1mindbomb E3 ubiquitin protein ligase 1Kidney+3.510.004
239OLIG1oligodendrocyte transcription factor 1Kidney+3.500.004
240ACSBG1acyl-CoA synthetase bubblegum family member 1Kidney+3.490.001
241SLC17A4solute carrier family 17, member 4Kidney+3.480.022
242PLA2G7phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)Kidney+3.470.004
243NRIP3nuclear receptor interacting protein 3Kidney+3.460.008
244ERP27endoplasmic reticulum protein 27Kidney+3.450.000
245C1orf53chromosome 1 open reading frame 53Kidney+3.450.040
246EBF2early B-cell factor 2Kidney+3.440.020
247TGFBRAP1transforming growth factor, beta receptor associated protein 1Kidney+3.430.001
248NKX2-3NK2 homeobox 3Kidney+3.420.023
249ARSJarylsulfatase family, member JKidney+3.420.000
250MTFR1mitochondrial fission regulator 1Kidney+3.410.000
251MUC20mucin 20, cell surface associatedKidney+3.400.005
252SLC9A2solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2Kidney+3.390.012
253SLIT2slit guidance ligand 2Kidney+3.380.005
254PSG9pregnancy specific beta-1-glycoprotein 9Kidney+3.360.001
255UBE2QL1ubiquitin-conjugating enzyme E2Q family-like 1Kidney+3.330.000
256LOC441666zinc finger protein 91 pseudogeneKidney+3.320.048
257TREM2triggering receptor expressed on myeloid cells 2Kidney+3.320.001
258ZBTB43zinc finger and BTB domain containing 43Kidney+3.310.007
259TMPRSS15transmembrane protease, serine 15Kidney+3.300.010
260SPSB4splA/ryanodine receptor domain and SOCS box containing 4Kidney+3.290.000
261SYT17synaptotagmin XVIIKidney+3.290.001
262CYP11A1cytochrome P450, family 11, subfamily A, polypeptide 1Kidney+3.280.022
263FNDC5fibronectin type III domain containing 5Kidney+3.280.035
264PKIBprotein kinase (cAMP-dependent, catalytic) inhibitor betaKidney+3.280.042
265GINS2GINS complex subunit 2 (Psf2 homolog)Kidney+3.280.007
266ATP2B2ATPase, Ca++ transporting, plasma membrane 2Kidney+3.280.013
267IGF2BP3insulin-like growth factor 2 mRNA binding protein 3Kidney+3.250.002
268MAGIXMAGI family member, X-linkedKidney+3.240.001
269HCRThypocretin (orexin) neuropeptide precursorKidney+3.230.003
270SOCS1suppressor of cytokine signaling 1Kidney+3.230.000
271MTSS1metastasis suppressor 1Kidney+3.210.047
272BTG3BTG family, member 3Kidney+3.200.016
273OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEFKidney+3.190.018
274BAIAP2L1BAI1-associated protein 2-like 1Kidney+3.170.009
275VSIG10LV-set and immunoglobulin domain containing 10 likeKidney+3.170.016
276APOBEC3Bapolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3BKidney+3.160.000
277OTUD7AOTU deubiquitinase 7AKidney+3.160.008
278GAB2GRB2-associated binding protein 2Kidney+3.150.010
279TIMD4T-cell immunoglobulin and mucin domain containing 4Kidney+3.140.007
280GLDNgliomedinKidney+3.130.041
281HIST3H2Ahistone cluster 3, H2aKidney+3.130.000
282DDX28DEAD (Asp-Glu-Ala-Asp) box polypeptide 28Kidney+3.110.018
283NOP14-AS1NOP14 antisense RNA 1Kidney+3.110.014
284C7orf57chromosome 7 open reading frame 57Kidney+3.100.014
285KLRD1killer cell lectin-like receptor subfamily D, member 1Kidney+3.100.015
286DNASE1deoxyribonuclease IKidney+3.090.016
287NPTXRneuronal pentraxin receptorKidney+3.080.005
288LOC400794uncharacterized LOC400794Kidney+3.080.004
289PGBD4piggyBac transposable element derived 4Kidney+3.070.017
290PLCG2phospholipase C, gamma 2 (phosphatidylinositol-specific)Kidney+3.070.003
291KRTAP9-3keratin associated protein 9-3Kidney+3.050.033
292IL18interleukin 18Kidney+3.040.001
293DRAXINdorsal inhibitory axon guidance proteinKidney+3.030.032
294RARRES3retinoic acid receptor responder (tazarotene induced) 3Kidney+3.030.007
295FAM228Afamily with sequence similarity 228, member AKidney+3.030.034
296ELAVL2ELAV like neuron-specific RNA binding protein 2Kidney+3.000.034
297KIAA1324KIAA1324Kidney+3.000.009

Search GEO for disease gene expression data for Chromophobe Renal Cell Carcinoma.

Pathways for genes affiliated with Chromophobe Renal Cell Carcinoma

About this section

GO Terms for genes affiliated with Chromophobe Renal Cell Carcinoma

About this section

Cellular components related to Chromophobe Renal Cell Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1apicolateral plasma membraneGO:001632710.1CLDN7, CLDN8, KRT8
2basolateral plasma membraneGO:00163239.9CDH16, CLDN7, CLDN8, EPCAM
3bicellular tight junctionGO:00059239.8CCND1, CLDN7, CLDN8, EPCAM
4keratin filamentGO:00450959.5KRT18, KRT7, KRT8
5extracellular exosomeGO:00700627.8AMY1A, CDH16, EPCAM, KRT18, KRT7, KRT8

Biological processes related to Chromophobe Renal Cell Carcinoma according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferationGO:005067310.8HNF1B, KIT
2positive regulation of transcription initiation from RNA polymerase II promoterGO:006026110.7HNF1A, HNF1B
3regulation of pronephros sizeGO:003556510.7HNF1A, HNF1B
4hepatocyte apoptotic processGO:009728410.7KRT18, KRT8
5germ cell migrationGO:000835410.6KIT, TGFB1
6liver developmentGO:000188910.5CCND1, HNF1A, HNF1B
7response to glucoseGO:000974910.3HNF1A, HNF1B, TGFB1
8extrinsic apoptotic signaling pathwayGO:009719110.3KRT18, KRT8, TGFB1
9positive regulation of cell motilityGO:200014710.3CLDN7, EPCAM
10negative regulation of epithelial cell differentiationGO:003085710.0CAV1, CCND1
11cornificationGO:00702689.9KRT18, KRT7, KRT8, PRSS8
12MAPK cascadeGO:00001659.4CAV1, KIT, PSMB9, TGFB1
13positive regulation of cell proliferationGO:00082849.2CCND1, CLDN7, EPCAM, KIT, TGFB1
14negative regulation of transcription from RNA polymerase II promoterGO:00001228.7CAV1, CCND1, FLCN, HNF1B, S100A1, TGFB1
15viral processGO:00160328.3CAV1, KRT18, KRT7, KRT8, PSMB9

Molecular functions related to Chromophobe Renal Cell Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endopeptidase activityGO:000417510.4MME, PRSS8, PSMB9
2protein complex bindingGO:00324039.9CCND1, EPCAM, FLCN, HNF1B, KRT8
3protein heterodimerization activityGO:00469829.0CAV1, HNF1A, HNF1B, PVALB, TGFB1
4protein homodimerization activityGO:00428039.0HNF1A, HNF1B, KIT, PVALB, S100A1, TGFB1
5structural molecule activityGO:00051987.8CAV1, CLDN7, CLDN8, KRT18, KRT7, KRT8
6protein bindingGO:00055155.0AMY1A, CAV1, CCND1, CLDN7, CLDN8, EPCAM

Sources for Chromophobe Renal Cell Carcinoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet